US FDA expands use of Avadel's sleep disorder drug to ages 7 and up
The U.S. Food and Drug Administration has approved Avadel Pharmaceuticals' sleep disorder drug for children aged 7 years and ...
FDA identifies food safety issues at Delta food preparation facility
Passengers on 200 Delta flights were denied in-flight meal service after food safety issues were discovered in the airline's ...
Cure Today5h
FDA Accepts New Drug Application for UGN-102 in Bladder Cancer
The FDA has accepted a new drug application for the intravesical solution of UGN-102 in low-grade intermediate-risk ...
FDA issues recall notices for two brands of pet food over salmonella and listeria contamination
Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them ...
US FDA approves Pfizer's drug for rare bleeding disorder
The U.S. Food and Drug Administration approved Pfizer's once-a-week injection for the two main types of a rare bleeding ...
JD Supra9d
GLP-1 Drugs: FDA Removes Lilly’s Zepbound® and Mounjaro® (tirzepatide injection) from its Drug Shortage List
On October 2, 2024, the U.S. Food and Drug Administration (FDA) determined the shortage of the tirzepatide injection, a glucagon-like peptide ...
UPI21d
FDA approves new schizophrenia drug
Sept. 26 (UPI) --The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday. The drug, generically called Cobenfy, is the first oral ...
Delta cancels meal service on hundreds of flights after FDA flags ‘food safety issue’
Food and Drug Administration officials were conducting a routine inspection at the kitchen of Delta’s catering partner when ...
ABC News21d
FDA approves 1st new drug for schizophrenia in more than 30 years
The medication, Cobenfy, combines two drugs and is taken as a twice-daily pill. The U.S. Food and Drug Administration (FDA) on Thursday approved the first new drug to treat people with ...
The Washington Post20d
FDA approves a novel drug for schizophrenia, a potential ‘game changer’
The U.S. Food and Drug Administration late Thursday approved ... treatment in decades,” Tiffany Farchione, director of FDA’s division of psychiatry, said in a statement.
Business Wire20d
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of ...
today announced that the U.S. Food and Drug Administration (FDA) has approved COBENFY™ (xanomeline and trospium chloride), an oral medication for the treatment of schizophrenia in adults.
Hoodline4h
FDA-Approved Breast Cancer Drug Shows Promise for Rare Appendix Cancer, UC San Diego Study Reveals
The study highlights a breast cancer drug's potential for treating rare appendix cancer, showing promising results in a ...